We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Register to vote Register by 18 June to vote in the General Election on 4 July.
COMEAP statement on the evidence of health effects from exposure to nitrogen dioxide.
This report (HPA-CHaPD-001) is a review of environmental chemicals and neurotoxicity focusing on neurological diseases.
Safety leaflet on opioid medicines to help patients and their families reduce the risks of harm.
Find out about the long-term effects some people can have after having COVID-19.
Information for patients, healthcare professionals and developers of new medicines
Information on phenol (also known as carbolic acid and hydroxybenzene), for responding to chemical incidents.
The most recent scientific research on exposure to electric and magnetic fields.
Report a problem ('adverse incident') with a medical device or medicine to MHRA using the Yellow Card Scheme
Whether you’re a patient, healthcare professional or carer, this year’s #MedSafetyWeek campaign is calling on you to help improve the safety of medical products by reporting any suspected side effects and adverse incidents to the MHRA Yellow Card scheme.
Guidance on acetic acid (also known as ethanoic acid) for use in responding to chemical incidents.
Information on chloroform (also known as trichloromethane or methyl trichloride), for use in responding to chemical incidents.
Further measures to be introduced to ensure patients who are prescribed montelukast for the treatment of asthma are informed of the risk of neuropsychiatric reactions
Information for public health professionals on immunisation.
How to prepare and what to do if you’re affected by extreme weather and natural hazards while travelling or living abroad.
How to identify and report harmful trade practices that affect your business when exporting, importing or operating domestically.
Information about mercury, for use in responding to chemical incidents.
Information on acrylonitrile (2-propenenitrile; cyanoethylene; vinyl cyanide) for use in responding to chemical incidents.
A cross-sectional study on the protective role of parental monitoring, religiosity, and self-esteem
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).